Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli
Identifieur interne : 001406 ( PascalFrancis/Corpus ); précédent : 001405; suivant : 001407Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli
Auteurs : Makrina Totsika ; Timothy J. Wells ; Christophe Beloin ; Jaione Valle ; Luke P. Allsopp ; Nathan P. King ; Jean-Marc Ghigo ; Mark A. SchembriSource :
- Applied and environmental microbiology : (Print) [ 0099-2240 ] ; 2012.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Trimeric autotransporter proteins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. A common feature of most TAAs is the ability to mediate adherence to eukaryotic cells or extracellular matrix (ECM) proteins via a cell surface-exposed passenger domain. Here we describe the characterization of EhaG, a TAA identified from enterohemorrhagic Escherichia coli (EHEC) O157:H7. EhaG is a positional orthologue of the recently characterized UpaG TAA from uropathogenic E. coli (UPEC). Similarly to UpaG, EhaG localized at the bacterial cell surface and promoted cell aggregation, biofilm formation, and adherence to a range of ECM proteins. However, the two orthologues display differential cellular binding: EhaG mediates specific adhesion to colorectal epithelial cells while UpaG promotes specific binding to bladder epithelial cells. The EhaG and UpaG TAAs contain extensive sequence divergence in their respective passenger domains that could account for these differences. Indeed, sequence analyses of UpaG and EhaG homologues from several E. coli genomes revealed grouping of the proteins in clades almost exclusively represented by distinct E. coli pathotypes. The expression of EhaG (in EHEC) and UpaG (in UPEC) was also investigated and shown to be significantly enhanced in an hns isogenic mutant, suggesting that H-NS acts as a negative regulator of both TAAs. Thus, while the EhaG and UpaG TAAs contain some conserved binding and regulatory features, they also possess important differences that correlate with the distinct pathogenic lifestyles of EHEC and UPEC.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 12-0203390 INIST |
---|---|
ET : | Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli |
AU : | TOTSIKA (Makrina); WELLS (Timothy J.); BELOIN (Christophe); VALLE (Jaione); ALLSOPP (Luke P.); KING (Nathan P.); GHIGO (Jean-Marc); SCHEMBRI (Mark A.) |
AF : | Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland/Brisbane, QLD/Australie (1 aut., 2 aut., 5 aut., 6 aut., 8 aut.); Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie/Paris/France (3 aut., 4 aut., 7 aut.); CNRS, URA2172/Paris/France (3 aut., 7 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Applied and environmental microbiology : (Print); ISSN 0099-2240; Coden AEMIDF; Etats-Unis; Da. 2012; Vol. 78; No. 7; Pp. 2179-2189; Bibl. 60 ref. |
LA : | Anglais |
EA : | Trimeric autotransporter proteins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. A common feature of most TAAs is the ability to mediate adherence to eukaryotic cells or extracellular matrix (ECM) proteins via a cell surface-exposed passenger domain. Here we describe the characterization of EhaG, a TAA identified from enterohemorrhagic Escherichia coli (EHEC) O157:H7. EhaG is a positional orthologue of the recently characterized UpaG TAA from uropathogenic E. coli (UPEC). Similarly to UpaG, EhaG localized at the bacterial cell surface and promoted cell aggregation, biofilm formation, and adherence to a range of ECM proteins. However, the two orthologues display differential cellular binding: EhaG mediates specific adhesion to colorectal epithelial cells while UpaG promotes specific binding to bladder epithelial cells. The EhaG and UpaG TAAs contain extensive sequence divergence in their respective passenger domains that could account for these differences. Indeed, sequence analyses of UpaG and EhaG homologues from several E. coli genomes revealed grouping of the proteins in clades almost exclusively represented by distinct E. coli pathotypes. The expression of EhaG (in EHEC) and UpaG (in UPEC) was also investigated and shown to be significantly enhanced in an hns isogenic mutant, suggesting that H-NS acts as a negative regulator of both TAAs. Thus, while the EhaG and UpaG TAAs contain some conserved binding and regulatory features, they also possess important differences that correlate with the distinct pathogenic lifestyles of EHEC and UPEC. |
CC : | 002A05 |
FD : | Caractérisation; Protéine; Pathogène; Escherichia coli |
FG : | Enterobacteriaceae; Bactérie |
ED : | Characterization; Protein; Pathogenic; Escherichia coli |
EG : | Enterobacteriaceae; Bacteria |
SD : | Caracterización; Proteína; Patógeno; Escherichia coli |
LO : | INIST-7195.354000509828760130 |
ID : | 12-0203390 |
Links to Exploration step
Pascal:12-0203390Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli</title>
<author><name sortKey="Totsika, Makrina" sort="Totsika, Makrina" uniqKey="Totsika M" first="Makrina" last="Totsika">Makrina Totsika</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wells, Timothy J" sort="Wells, Timothy J" uniqKey="Wells T" first="Timothy J." last="Wells">Timothy J. Wells</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Beloin, Christophe" sort="Beloin, Christophe" uniqKey="Beloin C" first="Christophe" last="Beloin">Christophe Beloin</name>
<affiliation><inist:fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>CNRS, URA2172</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valle, Jaione" sort="Valle, Jaione" uniqKey="Valle J" first="Jaione" last="Valle">Jaione Valle</name>
<affiliation><inist:fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Allsopp, Luke P" sort="Allsopp, Luke P" uniqKey="Allsopp L" first="Luke P." last="Allsopp">Luke P. Allsopp</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="King, Nathan P" sort="King, Nathan P" uniqKey="King N" first="Nathan P." last="King">Nathan P. King</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ghigo, Jean Marc" sort="Ghigo, Jean Marc" uniqKey="Ghigo J" first="Jean-Marc" last="Ghigo">Jean-Marc Ghigo</name>
<affiliation><inist:fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>CNRS, URA2172</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schembri, Mark A" sort="Schembri, Mark A" uniqKey="Schembri M" first="Mark A." last="Schembri">Mark A. Schembri</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0203390</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0203390 INIST</idno>
<idno type="RBID">Pascal:12-0203390</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001406</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli</title>
<author><name sortKey="Totsika, Makrina" sort="Totsika, Makrina" uniqKey="Totsika M" first="Makrina" last="Totsika">Makrina Totsika</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wells, Timothy J" sort="Wells, Timothy J" uniqKey="Wells T" first="Timothy J." last="Wells">Timothy J. Wells</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Beloin, Christophe" sort="Beloin, Christophe" uniqKey="Beloin C" first="Christophe" last="Beloin">Christophe Beloin</name>
<affiliation><inist:fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>CNRS, URA2172</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valle, Jaione" sort="Valle, Jaione" uniqKey="Valle J" first="Jaione" last="Valle">Jaione Valle</name>
<affiliation><inist:fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Allsopp, Luke P" sort="Allsopp, Luke P" uniqKey="Allsopp L" first="Luke P." last="Allsopp">Luke P. Allsopp</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="King, Nathan P" sort="King, Nathan P" uniqKey="King N" first="Nathan P." last="King">Nathan P. King</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ghigo, Jean Marc" sort="Ghigo, Jean Marc" uniqKey="Ghigo J" first="Jean-Marc" last="Ghigo">Jean-Marc Ghigo</name>
<affiliation><inist:fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>CNRS, URA2172</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schembri, Mark A" sort="Schembri, Mark A" uniqKey="Schembri M" first="Mark A." last="Schembri">Mark A. Schembri</name>
<affiliation><inist:fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Applied and environmental microbiology : (Print)</title>
<title level="j" type="abbreviated">Appl. environ. microbiol. : (Print)</title>
<idno type="ISSN">0099-2240</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Applied and environmental microbiology : (Print)</title>
<title level="j" type="abbreviated">Appl. environ. microbiol. : (Print)</title>
<idno type="ISSN">0099-2240</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Characterization</term>
<term>Escherichia coli</term>
<term>Pathogenic</term>
<term>Protein</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Caractérisation</term>
<term>Protéine</term>
<term>Pathogène</term>
<term>Escherichia coli</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Trimeric autotransporter proteins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. A common feature of most TAAs is the ability to mediate adherence to eukaryotic cells or extracellular matrix (ECM) proteins via a cell surface-exposed passenger domain. Here we describe the characterization of EhaG, a TAA identified from enterohemorrhagic Escherichia coli (EHEC) O157:H7. EhaG is a positional orthologue of the recently characterized UpaG TAA from uropathogenic E. coli (UPEC). Similarly to UpaG, EhaG localized at the bacterial cell surface and promoted cell aggregation, biofilm formation, and adherence to a range of ECM proteins. However, the two orthologues display differential cellular binding: EhaG mediates specific adhesion to colorectal epithelial cells while UpaG promotes specific binding to bladder epithelial cells. The EhaG and UpaG TAAs contain extensive sequence divergence in their respective passenger domains that could account for these differences. Indeed, sequence analyses of UpaG and EhaG homologues from several E. coli genomes revealed grouping of the proteins in clades almost exclusively represented by distinct E. coli pathotypes. The expression of EhaG (in EHEC) and UpaG (in UPEC) was also investigated and shown to be significantly enhanced in an hns isogenic mutant, suggesting that H-NS acts as a negative regulator of both TAAs. Thus, while the EhaG and UpaG TAAs contain some conserved binding and regulatory features, they also possess important differences that correlate with the distinct pathogenic lifestyles of EHEC and UPEC.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0099-2240</s0>
</fA01>
<fA02 i1="01"><s0>AEMIDF</s0>
</fA02>
<fA03 i2="1"><s0>Appl. environ. microbiol. : (Print)</s0>
</fA03>
<fA05><s2>78</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>TOTSIKA (Makrina)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>WELLS (Timothy J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BELOIN (Christophe)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>VALLE (Jaione)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>ALLSOPP (Luke P.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>KING (Nathan P.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>GHIGO (Jean-Marc)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SCHEMBRI (Mark A.)</s1>
</fA11>
<fA14 i1="01"><s1>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland</s1>
<s2>Brisbane, QLD</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>CNRS, URA2172</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>2179-2189</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>7195</s2>
<s5>354000509828760130</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>60 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0203390</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Applied and environmental microbiology : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Trimeric autotransporter proteins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. A common feature of most TAAs is the ability to mediate adherence to eukaryotic cells or extracellular matrix (ECM) proteins via a cell surface-exposed passenger domain. Here we describe the characterization of EhaG, a TAA identified from enterohemorrhagic Escherichia coli (EHEC) O157:H7. EhaG is a positional orthologue of the recently characterized UpaG TAA from uropathogenic E. coli (UPEC). Similarly to UpaG, EhaG localized at the bacterial cell surface and promoted cell aggregation, biofilm formation, and adherence to a range of ECM proteins. However, the two orthologues display differential cellular binding: EhaG mediates specific adhesion to colorectal epithelial cells while UpaG promotes specific binding to bladder epithelial cells. The EhaG and UpaG TAAs contain extensive sequence divergence in their respective passenger domains that could account for these differences. Indeed, sequence analyses of UpaG and EhaG homologues from several E. coli genomes revealed grouping of the proteins in clades almost exclusively represented by distinct E. coli pathotypes. The expression of EhaG (in EHEC) and UpaG (in UPEC) was also investigated and shown to be significantly enhanced in an hns isogenic mutant, suggesting that H-NS acts as a negative regulator of both TAAs. Thus, while the EhaG and UpaG TAAs contain some conserved binding and regulatory features, they also possess important differences that correlate with the distinct pathogenic lifestyles of EHEC and UPEC.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Caractérisation</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Characterization</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Caracterización</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Protéine</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Protein</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Proteína</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathogène</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Pathogenic</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Patógeno</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Escherichia coli</s0>
<s2>NS</s2>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Escherichia coli</s0>
<s2>NS</s2>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Escherichia coli</s0>
<s2>NS</s2>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Enterobacteriaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Enterobacteriaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Enterobacteriaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Bactérie</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Bacteria</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Bacteria</s0>
</fC07>
<fN21><s1>156</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 12-0203390 INIST</NO>
<ET>Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli</ET>
<AU>TOTSIKA (Makrina); WELLS (Timothy J.); BELOIN (Christophe); VALLE (Jaione); ALLSOPP (Luke P.); KING (Nathan P.); GHIGO (Jean-Marc); SCHEMBRI (Mark A.)</AU>
<AF>Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland/Brisbane, QLD/Australie (1 aut., 2 aut., 5 aut., 6 aut., 8 aut.); Institut Pasteur, Unité de Génétique des Biofilms, Département de Microbiologie/Paris/France (3 aut., 4 aut., 7 aut.); CNRS, URA2172/Paris/France (3 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Applied and environmental microbiology : (Print); ISSN 0099-2240; Coden AEMIDF; Etats-Unis; Da. 2012; Vol. 78; No. 7; Pp. 2179-2189; Bibl. 60 ref.</SO>
<LA>Anglais</LA>
<EA>Trimeric autotransporter proteins (TAAs) are important virulence factors of many Gram-negative bacterial pathogens. A common feature of most TAAs is the ability to mediate adherence to eukaryotic cells or extracellular matrix (ECM) proteins via a cell surface-exposed passenger domain. Here we describe the characterization of EhaG, a TAA identified from enterohemorrhagic Escherichia coli (EHEC) O157:H7. EhaG is a positional orthologue of the recently characterized UpaG TAA from uropathogenic E. coli (UPEC). Similarly to UpaG, EhaG localized at the bacterial cell surface and promoted cell aggregation, biofilm formation, and adherence to a range of ECM proteins. However, the two orthologues display differential cellular binding: EhaG mediates specific adhesion to colorectal epithelial cells while UpaG promotes specific binding to bladder epithelial cells. The EhaG and UpaG TAAs contain extensive sequence divergence in their respective passenger domains that could account for these differences. Indeed, sequence analyses of UpaG and EhaG homologues from several E. coli genomes revealed grouping of the proteins in clades almost exclusively represented by distinct E. coli pathotypes. The expression of EhaG (in EHEC) and UpaG (in UPEC) was also investigated and shown to be significantly enhanced in an hns isogenic mutant, suggesting that H-NS acts as a negative regulator of both TAAs. Thus, while the EhaG and UpaG TAAs contain some conserved binding and regulatory features, they also possess important differences that correlate with the distinct pathogenic lifestyles of EHEC and UPEC.</EA>
<CC>002A05</CC>
<FD>Caractérisation; Protéine; Pathogène; Escherichia coli</FD>
<FG>Enterobacteriaceae; Bactérie</FG>
<ED>Characterization; Protein; Pathogenic; Escherichia coli</ED>
<EG>Enterobacteriaceae; Bacteria</EG>
<SD>Caracterización; Proteína; Patógeno; Escherichia coli</SD>
<LO>INIST-7195.354000509828760130</LO>
<ID>12-0203390</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001406 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001406 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:12-0203390 |texte= Molecular Characterization of the EhaG and UpaG Trimeric Autotransporter Proteins from Pathogenic Escherichia coli }}
This area was generated with Dilib version V0.6.33. |